Source: Mesoblast Limited
Date: August 10, 2007
Summary:
Mesoblast Limited has announced the successful conclusion of the Australian Cardiac Pilot Trial it had been conducting together with its United States-based sister company Angioblast Systems Inc. at John Hunter Hospital in New South Wales. All patients injected with their own, or autologous, stem cells showed improvement in either symptoms of heart failure or function.
